The Independent reports that researchers at Imperial College London are shifting away from testing a COVID-19 vaccine they developed to instead focus on targeting newly emerging SARS-CoV-2 variants.
The Independent reports that researchers at Imperial College London are shifting away from testing a COVID-19 vaccine they developed to instead focus on targeting newly emerging SARS-CoV-2 variants.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.